Ghost Tree Capital as of June 30, 2024
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 60 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 6.9 | $22M | 91k | 243.00 | |
| Insmed Com Par $.01 (INSM) | 5.6 | $18M | 265k | 67.00 | |
| Biohaven (BHVN) | 5.3 | $17M | 490k | 34.71 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 4.1 | $13M | 300k | 43.97 | |
| Soleno Therapeutics (SLNO) | 3.8 | $12M | 300k | 40.80 | |
| Axsome Therapeutics (AXSM) | 3.8 | $12M | 150k | 80.50 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.7 | $12M | 87k | 136.38 | |
| Vaxcyte (PCVX) | 3.5 | $11M | 150k | 75.51 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.4 | $11M | 240k | 44.79 | |
| Roivant Sciences SHS (ROIV) | 3.3 | $11M | 1.0M | 10.57 | |
| Perspective Therapeutics Com New (CATX) | 2.9 | $9.2M | 925k | 9.97 | |
| Tg Therapeutics (TGTX) | 2.8 | $8.9M | 500k | 17.79 | |
| Sarepta Therapeutics (SRPT) | 2.7 | $8.7M | 55k | 158.00 | |
| Cg Oncology (CGON) | 2.6 | $8.2M | 260k | 31.57 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 2.5 | $7.9M | 175k | 45.25 | |
| Miragen Therapeutics (VRDN) | 2.4 | $7.6M | 588k | 13.01 | |
| Syndax Pharmaceuticals (SNDX) | 2.3 | $7.2M | 350k | 20.53 | |
| Immunovant (IMVT) | 2.1 | $6.9M | 260k | 26.40 | |
| Tarsus Pharmaceuticals (TARS) | 2.0 | $6.4M | 235k | 27.18 | |
| Phathom Pharmaceuticals (PHAT) | 1.9 | $6.2M | 600k | 10.30 | |
| Rezolute Com New (RZLT) | 1.9 | $6.1M | 1.4M | 4.30 | |
| Olema Pharmaceuticals (OLMA) | 1.9 | $6.0M | 550k | 10.82 | |
| Spyre Therapeutics Com New (SYRE) | 1.8 | $5.9M | 250k | 23.51 | |
| Apellis Pharmaceuticals (APLS) | 1.6 | $5.2M | 135k | 38.36 | |
| Viking Therapeutics (VKTX) | 1.6 | $5.0M | 95k | 53.01 | |
| Rhythm Pharmaceuticals (RYTM) | 1.5 | $4.8M | 117k | 41.06 | |
| Blueprint Medicines (BPMC) | 1.4 | $4.3M | 40k | 107.78 | |
| Savara (SVRA) | 1.3 | $4.2M | 1.1M | 4.03 | |
| Tenaya Therapeutics (TNYA) | 1.3 | $4.2M | 1.4M | 3.10 | |
| Replimune Group (REPL) | 1.3 | $4.1M | 450k | 9.00 | |
| Engene Holdings (ENGN) | 1.2 | $4.0M | 420k | 9.43 | |
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $3.7M | 225k | 16.25 | |
| Bridgebio Pharma (BBIO) | 1.1 | $3.5M | 140k | 25.33 | |
| Korro Bio (KRRO) | 1.1 | $3.4M | 100k | 33.87 | |
| Nuvation Bio Com Cl A (NUVB) | 1.1 | $3.4M | 1.2M | 2.92 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.0 | $3.1M | 300k | 10.22 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.9 | $2.8M | 1.3M | 2.24 | |
| Cabaletta Bio (CABA) | 0.9 | $2.8M | 371k | 7.48 | |
| Annexon (ANNX) | 0.8 | $2.6M | 525k | 4.90 | |
| Neurogene (NGNE) | 0.8 | $2.5M | 70k | 36.39 | |
| Janux Therapeutics (JANX) | 0.7 | $2.1M | 50k | 41.89 | |
| Arvinas Ord (ARVN) | 0.6 | $2.0M | 75k | 26.62 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $2.0M | 170k | 11.70 | |
| Cytokinetics Com New (CYTK) | 0.6 | $1.8M | 33k | 54.18 | |
| Elevation Oncology (ELEV) | 0.5 | $1.6M | 600k | 2.70 | |
| Krystal Biotech (KRYS) | 0.5 | $1.6M | 8.5k | 183.64 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.5 | $1.5M | 900k | 1.66 | |
| Atyr Pharma Com New (ATYR) | 0.4 | $1.2M | 800k | 1.56 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $998k | 200k | 4.99 | |
| Rapt Therapeutics Call Option (RAPT) | 0.3 | $915k | 300k | 3.05 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $910k | 35k | 25.99 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.2 | $770k | 225k | 3.42 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $685k | 10k | 68.49 | |
| Macrogenics (MGNX) | 0.2 | $638k | 150k | 4.25 | |
| Pmv Pharmaceuticals (PMVP) | 0.2 | $608k | 375k | 1.62 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $581k | 19k | 30.58 | |
| Revance Therapeutics (RVNC) | 0.2 | $578k | 225k | 2.57 | |
| Intellia Therapeutics (NTLA) | 0.2 | $560k | 25k | 22.38 | |
| An2 Therapeutics (ANTX) | 0.1 | $472k | 219k | 2.15 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $366k | 300k | 1.22 |
